Japan Pedicle Screw Systems Market

ID: MRFR/HC/51952-HCR
200 Pages
Satyendra Maurya
Last Updated: February 06, 2026
Japan Pedicle Screw Systems Market Research Report: Size, Share, Trend Analysis By Surgery Type (Open Surgery, Minimally Invasive Surgery), By Product Type (Polyaxial Pedicle Screw Systems, Monoaxial Pedicle Screw Systems), By Indication (Spinal Degeneration, Spinal Trauma, Spinal Deformities, Others), By Applications (Thoracolumbar Fusion, Spinal Cervical Fusion) andBy End Users (Hospitals, Clinics, Research Organization, Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Pedicle Screw Systems Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.97%
2024 Market Size$ 33.12 Million
2025 Market Size$ 34.77 Million
2035 Market Size$ 56.5 Million

Key Players

Medtronic
DePuy Synthes
Stryker
Zimmer Biomet
NuVasive
Globus Medical
Opportunities
  • Increasing Incidence of Spinal Disorders
  • Technological Innovations in Surgical Tools
  • Enhanced Training and Education for Surgeons
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Surgery Type (USD Million)
      1. 4.1.1 Open Surgery
      2. 4.1.2 Minimally Invasive Surgery
    2. 4.2 Life Sciences, BY Product Type (USD Million)
      1. 4.2.1 Polyaxial Pedicle Screw Systems
      2. 4.2.2 Monoaxial Pedicle Screw Systems
    3. 4.3 Life Sciences, BY Indication (USD Million)
      1. 4.3.1 Spinal Degeneration
      2. 4.3.2 Spinal Trauma
      3. 4.3.3 Spinal Deformities
      4. 4.3.4 Others
    4. 4.4 Life Sciences, BY Application (USD Million)
      1. 4.4.1 Thoracolumbar Fusion
      2. 4.4.2 Spinal Cervical Fusion
    5. 4.5 Life Sciences, BY End-User (USD Million)
      1. 4.5.1 Hospitals
      2. 4.5.2 Clinics
      3. 4.5.3 Research Organizations
      4. 4.5.4 Academic Institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 DePuy Synthes (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Stryker (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Zimmer Biomet (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 NuVasive (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Globus Medical (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Orthofix (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 K2M (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 JAPAN MARKET ANALYSIS BY SURGERY TYPE
    3. 6.3 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 JAPAN MARKET ANALYSIS BY INDICATION
    5. 6.5 JAPAN MARKET ANALYSIS BY APPLICATION
    6. 6.6 JAPAN MARKET ANALYSIS BY END-USER
    7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
    10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    13. 6.13 LIFE SCIENCES, BY SURGERY TYPE, 2024 (% SHARE)
    14. 6.14 LIFE SCIENCES, BY SURGERY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 LIFE SCIENCES, BY INDICATION, 2024 (% SHARE)
    18. 6.18 LIFE SCIENCES, BY INDICATION, 2024 TO 2035 (USD Million)
    19. 6.19 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
    22. 6.22 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SURGERY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY INDICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Japan Life Sciences Market Segmentation

Life Sciences By Surgery Type (USD Million, 2025-2035)

  • Open Surgery
  • Minimally Invasive Surgery

Life Sciences By Product Type (USD Million, 2025-2035)

  • Polyaxial Pedicle Screw Systems
  • Monoaxial Pedicle Screw Systems

Life Sciences By Indication (USD Million, 2025-2035)

  • Spinal Degeneration
  • Spinal Trauma
  • Spinal Deformities
  • Others

Life Sciences By Application (USD Million, 2025-2035)

  • Thoracolumbar Fusion
  • Spinal Cervical Fusion

Life Sciences By End-User (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Research Organizations
  • Academic Institutes